Key points are not available for this paper at this time.
Toxicogenomics focuses on assessing the safety of compounds using gene expression profiles. Gene expression signatures from large toxicogenomics databases are expected to perform better than small databases in identifying biomarkers for the prediction and evaluation of drug safety based on a compound's toxicological mechanisms in animal target organs. Over the past 10 years, the Japanese Toxicogenomics Project consortium (TGP) has been developing a large-scale toxicogenomics database consisting of data from 170 compounds (mostly drugs) with the aim of improving and enhancing drug safety assessment. Most of the data generated by the project (e.g. gene expression, pathology, lot number) are freely available to the public via Open TG-GATEs (Toxicogenomics Project-Genomics Assisted Toxicity Evaluation System). Here, we provide a comprehensive overview of the database, including both gene expression data and metadata, with a description of experimental conditions and procedures used to generate the database. Open TG-GATEs is available from http://toxico.nibio.go.jp/english/index.html.
Building similarity graph...
Analyzing shared references across papers
Loading...
Yoshinobu Igarashi
National Institute of Biomedical Innovation, Health and Nutrition
Noriyuki Nakatsu
National Institute of Biomedical Innovation, Health and Nutrition
Tomoya Yamashita
Kobe University
Nucleic Acids Research
Hitachi (Japan)
National Institute of Health Sciences
National Institute of Biomedical Innovation, Health and Nutrition
Building similarity graph...
Analyzing shared references across papers
Loading...
Igarashi et al. (Mon,) studied this question.
synapsesocial.com/papers/6a20557d7a3568d6afd1f437 — DOI: https://doi.org/10.1093/nar/gku955
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: